GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Zymergen Inc (NAS:ZY) » Definitions » Price-to-Owner-Earnings

Zymergen (Zymergen) Price-to-Owner-Earnings : (As of May. 12, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Zymergen Price-to-Owner-Earnings?

As of today (2024-05-12), Zymergen's share price is $2.43. Zymergen does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Zymergen's Price-to-Owner-Earnings or its related term are showing as below:


ZY's Price-to-Owner-Earnings is not ranked *
in the Chemicals industry.
Industry Median: 19.66
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-05-12), Zymergen's share price is $2.43. Zymergen's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2022 was $-3.55. Therefore, Zymergen's PE Ratio for today is At Loss.

As of today (2024-05-12), Zymergen's share price is $2.43. Zymergen's EPS without NRI for the trailing twelve months (TTM) ended in was $-3.55. Therefore, Zymergen's PE Ratio without NRI for today is At Loss.


Zymergen Price-to-Owner-Earnings Historical Data

The historical data trend for Zymergen's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zymergen Price-to-Owner-Earnings Chart

Zymergen Annual Data
Trend Dec19 Dec20 Dec21
Price-to-Owner-Earnings
- - -

Zymergen Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Zymergen's Price-to-Owner-Earnings

For the Specialty Chemicals subindustry, Zymergen's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zymergen's Price-to-Owner-Earnings Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Zymergen's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Zymergen's Price-to-Owner-Earnings falls into.



Zymergen Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Zymergen's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=2.43/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zymergen  (NAS:ZY) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Zymergen Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Zymergen's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Zymergen (Zymergen) Business Description

Traded in Other Exchanges
N/A
Address
5980 Horton Street, Suite 105, Emeryville, CA, USA, 94608
Zymergen Inc is a biofacturing company. Zymergen partners with nature to design, develop and manufacture bio-based breakthrough products that deliver value to customers in a broad range of industries. A unique combination of biology, chemistry, software and automation enables the company to design and create new materials.
Executives
Enakshi Singh officer: Chief Financial Officer 5980 HORTON ST., STE 105 EMERYVILLE CA 94608
Mina Kim officer: Chief Legal Officer C/O ACELYRIN, INC., 4149 LIBERTY CANYON RD., AGOURA HILLS CA 91301
Zachariah Serber director, officer: Chief Science Officer 5980 HORTON ST., STE 105 EMERYVILLE CA 94608
Aaron Kimball officer: Chief Technology Officer 5980 HORTON ST., STE 105 EMERYVILLE CA 94025
Jay T Flatley director 9885 TOWNE CENTRE DR, SAN DIEGO CA 92121
Svf Excaliber (cayman) Ltd 10 percent owner 27 HOSPITAL ROAD, WALKERS CORPORATE LTD., CAYMAN CORPORATE CENTRE, GEORGE TOWN, GRAND CAYMAN E9 KY-9008
Josh Hoffman director, officer: Chief Executive Officer 5980 HORTON ST., STE 105 EMERYVILLE CA 94608
Erik Jedidiah Dean officer: VP Operations and Engineering 5980 HORTON ST., STE 105 EMERYVILLE CA 94608
Rohit Sharma director 575 HIGH STREET PALO ALTO CA 94301
Travis Murdoch director 1 CIRCLE STAR WAY SAN CARLOS CA 94070
Matthew Ocko director 270 UNIVERSITY AVENUE, PALO ALTO CA 94301
Svf Endurance (cayman) Ltd 10 percent owner C/O WALKERS CORPORATE LIMITED, 27 HOSPITAL ROAD, GEORGE TOWN E9 KY1-9008
Softbank Vision Fund (aiv M1) L.p. 10 percent owner 251 LITTLE FALLS DRIVE, WILMINGTON DE 19808
Sb Investment Advisers (uk) Ltd 10 percent owner 69 GROSVENOR STREET, LONDON X0 W1K 3JP
Christine Marie Gorjanc director 4500 GREAT AMERICA PARKWAY, SANTA CLARA CA 95054

Zymergen (Zymergen) Headlines